Glenmark Pharmaceuticals consolidated net profit rises 72.31% in the September 2025 quarter
Sales rise 76.56% to Rs 6003.79 crore
Net profit of Glenmark Pharmaceuticals rose 72.31% to Rs 610.35 crore in the quarter ended September 2025 as against Rs 354.21 crore during the previous quarter ended September 2024. Sales rose 76.56% to Rs 6003.79 crore in the quarter ended September 2025 as against Rs 3400.50 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales6003.793400.50 77 OPM %39.3017.70 -PBDT2493.72592.85 321 PBT2352.52472.57 398 NP610.35354.21 72Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 15 2025 | 9:01 AM IST